soft tissue sarcoma

Type: Keyphrase
Name: soft tissue sarcoma
First reported 1 hour ago - Updated 1 hour ago - 1 reports

Relay for Life fundraising underway

With 35 days remaining until Bartow’s Relay for Life, the event’s teams are busy generating funds for the American Cancer Society.“Everybody’s getting really excited. ... The response has been wonderful,” said Peggy Davis, Relay for Life specialist for ... [Published Cartersville Daily Tribune News - 1 hour ago]
First reported 2 hours ago - Updated 2 hours ago - 1 reports

Threshold Pharmaceuticals Reports Second Quarter 2014 Financial and Operational Results

SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 08/01/14 -- Threshold Pharmaceuticals"With progress made in the second quarter, TH-302 is now the subject of investigation in three large randomized trials, including two pivotal trials in patients with advanced ... [Published BusinessWeek - 2 hours ago]
First reported Jul 30 2014 - Updated Jul 30 2014 - 1 reports

A rewarding physical and mental feat

Determined and dedicated family members have saddled up successfully for a charity challenge in memory of Lundin Links man Henry Gibbon.Eleven relatives and friends completed a four-day July cycle trek to raise money for a range of cancer charities.The ... [Published Fife Today - Jul 30 2014]
First reported Jul 27 2014 - Updated Jul 27 2014 - 1 reports

Forum Post: RE: I'm one in, er, 2.5 million... epithelioid sarcoma

Soft tissue sarcomasA group for anyone affected by any type of soft tissue sarcoma, including those in the fat, muscle, peripheral nerves, synovial sarcomas and angiosarcomas. This is a place to get together, ask questions, share experiences and support ... [Published Macmillan Cancer Support - Jul 27 2014]
First reported Jul 20 2014 - Updated Jul 20 2014 - 1 reports

Forum Post: Side effects after doxorubicin treatment is finished?

Soft tissue sarcomasA group for anyone affected by any type of soft tissue sarcoma, including those in the fat, muscle, peripheral nerves, synovial sarcomas and angiosarcomas. This is a place to get together, ask questions, share experiences and support ... [Published Macmillan Cancer Support - Jul 20 2014]
First reported Jul 17 2014 - Updated Jul 18 2014 - 1 reports

BSD Medical initiates Phase I/II soft tissue sarcoma study

BSD Medical Corporation has initiated a Phase I/II study, HYPROSAR, using hyperthermia, delivered using either the BSD-2000 Hyperthermia System or the BSD-500 Hyperthermia System, combined with proton radiotherapy to treat patients with unresectable soft ... [Published Individual.com - Jul 17 2014]
First reported Jul 15 2014 - Updated Jul 16 2014 - 4 reports

BSD Medical Hyperthermia starts Hyprosar study to treat Soft Tissue Sarcoma

BSD Medical has started a Phase I/II study (Hyprosar) using hyperthermia, delivered using either the BSD-2000 Hyperthermia System or the BSD-500 Hyperthermia System, combined with proton radiotherapy to treat patients with unresectable soft tissue sa ... [Published Medical Devices Business Review - Jul 16 2014]
First reported Jul 16 2014 - Updated Jul 16 2014 - 1 reports

Prognostic significance of WT1 expression in soft tissue sarcoma

Soft tissue sarcomas (STS) are rare. We evaluated the WT1 protein expression level in various types of STS and elucidated the value of WT1 as a prognostic factor and a possible therapeutic target.Methods: Immunohistochemical staining for WT1 was performed ... [Published 7thSpace - Jul 16 2014]
First reported Jul 16 2014 - Updated Jul 16 2014 - 1 reports

Hundreds smile for Smiley

THE Great Lakes community showed their support for local man Jared Wynter on Sunday at the Smile for Smiley benefit. THE Great Lakes community showed their support for local man Jared Wynter on Sunday at the Smile for Smiley benefit. Jared, better known ... [Published Great Lakes Advocate - Jul 16 2014]
First reported Jul 15 2014 - Updated Jul 15 2014 - 1 reports

BSD initiates hyperthermia clinical trial

10:42 ET | About: BSD Medical Corporation (BSDM)BSD Medical (BSDM -2.7%) initiates a 28-patient Phase 1/2 clinical trial evaluating the use of hyperthermia combined with proton radiotherapy as a treatment for patients with unresectable soft tissue sarcoma. ... [Published Seeking Alpha - Jul 15 2014]
First reported Jul 14 2014 - Updated Jul 14 2014 - 1 reports

3 Health Care Stocks Primed For Big Moves

Throughout the spring, analysts at Lazard Capital and Leerink Swan kept pounding the table for little-known Insmed (Nasdaq: INSM).The analysts kept telling clients that Insmed's Arikace, which is an inhalable antiobiotic used in serious lung infections, ... [Published Yahoo! Finance - Jul 14 2014]
First reported Jul 11 2014 - Updated Jul 11 2014 - 1 reports

Soft Tissue Sarcoma Guidelines: Updated and 'Irradiated'

Soft Tissue Sarcoma: Updated GuidelinesSoft tissue sarcomas are rare solid tumors that are being increasingly classified and treated by subtype. Approximately 12,020 people will be diagnosed with a soft tissue sarcoma in the United States this year, and ... [Published Diabetes Care - Jul 11 2014]

Quotes

...registration in patients with advanced non-squamous non-small cell lung cancer," said Barry Selick, Ph D , Chief Executive Officer of Threshold. "In our pivotal trial of TH-302 in patients with soft tissue sarcoma, we expect that the pre-planned interim safety and efficacy analyses will be conducted by the trial's independent data monitoring committee (IDMC) in September of this year. The IDMC's analyses will be accompanied by their recommendation on next steps, which we plan to announce shortly thereafter. Beyond our major therapeutic areas of focus, we continue to investigate TH-302 in other types of tumors and continue to be encouraged by early data, particularly in glioblastoma and multiple myeloma, as presented in the second quarter at ASCO."
...Ken K Ren, Ph D , CASI's CEO, commented, "CFDA's approval of our application represents a significant and exciting milestone for CASI in the execution of our China and global integrated development strategy. Our Phase II TNBC trial of ENMD-2076 in the US is progressing as planned, and we can now further expand the trial into China with the recruitment of more patients."
Ken K Ren , Ph D , CASI's Chief Executive Officer, commented, "CFDA's approval of our application represents a significant and exciting milestone for CASI in the execution of our China and global integrated development strategy.  Our Phase II TNBC trial of ENMD-2076 in the U S is progressing as planned, and we can now further expand the trial into China with the recruitment of more patients. Data from the China trial can be combined with data being collected in the U S , and may lead to reaching a clinical inflection point faster. In addition, the China trial will enable us to evaluate the safety and efficacy of ENMD-2076 in the Chinese patient population, providing an opportunity to address unmet medical needs in the country.  Furthermore, data from this trial may be used to support our import drug registration in China in the future."
Datta concluded, "Consequently, for unresectable primary and recurrent soft tissue sarcomas, the thermoradiobiological and physical advantages of hyperthermia and proton beam radiotherapy could be expected to produce a greater tumour regression, higher tumour downstaging, superior resectability with organ and limb preservation and improved survival outcome without significant treatment related morbidity."

More Content

All (86) | News (57) | Reports (0) | Blogs (25) | Audio/Video (0) | Fact Sheets (0) | Press Releases (3)
sort by: Date | Relevance
Relay for Life fundraising underway [Published Cartersville Daily Tribune News - 1 hour ago]
Threshold Pharmaceuticals Reports Second Quarte... [Published BusinessWeek - 2 hours ago]
Medical Director Appointed at Memorial Sloan Ke... [Published Newswise - 18 hours ago]
A rewarding physical and mental feat [Published Fife Today - Jul 30 2014]
Challenging dedifferentiated liposarcoma identi... [Published BMC - Jul 28 2014]
Forum Post: RE: I'm one in, er, 2.5 million... ... [Published Macmillan Cancer Support - Jul 27 2014]
BSD MEDICAL : Begins Hyperthermia Clinical Study [Published 4 Traders - Jul 27 2014]
CASI receives CFDA approval to conduct Phase II... [Published Individual.com - Jul 25 2014]
Anticancer agent – panobinostat [Published Manufacturing Chemist - Jul 21 2014]
CASI Pharmaceuticals Receives Approval From CFD... [Published Michigan Live - Jul 21 2014]
Forum Post: Side effects after doxorubicin trea... [Published Macmillan Cancer Support - Jul 20 2014]
BSD MEDICAL : Initiates Hyperthermia Clinical S... [Published 4 Traders - Jul 18 2014]
BSD Medical initiates Phase I/II soft tissue sa... [Published Individual.com - Jul 17 2014]
BSD Medical Hyperthermia starts Hyprosar study ... [Published Medical Devices Business Review - Jul 16 2014]
Clinical study will combine hyperthermia with p... [Published MedicalPhysicsWeb - Jul 16 2014]
Prognostic significance of WT1 expression in so... [Published 7thSpace - Jul 16 2014]
Hundreds smile for Smiley [Published Great Lakes Advocate - Jul 16 2014]
Healthcare Review: Aratana Therapeutics, BSD Me... [Published BioMedReports - Jul 15 2014]
Forum Post: Success with doxorubicin? [Published Macmillan Cancer Support - Jul 15 2014]
BSD initiates hyperthermia clinical trial [Published Seeking Alpha - Jul 15 2014]
BSD Medical Hyperthermia Reports Initiation of ... [Published BioPortfolio - Jul 15 2014]
BSD Medical Hyperthermia Reports Initiation of ... [Published Business Wire Health News - Jul 15 2014]
CASI receives FDA orphan drug designation for h... [Published Individual.com - Jul 14 2014]
3 Health Care Stocks Primed For Big Moves [Published Yahoo! Finance - Jul 14 2014]
The Texas Medical Board vs. Stanislaw Burzynski... [Published ScienceBlogs : Combined Feed - Jul 14 2014]
SMALL CAP SHARE TIPS: Nanobiotix secures fundin... [Published This Is Money - Jul 14 2014]
The Texas Medical Board vs. Stanislaw Burzynski... [Published Science-Based Medicine - Jul 14 2014]
Soft Tissue Sarcoma Guidelines: Updated and 'Ir... [Published Diabetes Care - Jul 11 2014]
Nanobiotix revenues steady; investors focus on ... [Published Proactiveinvestors United Kingdom website - Jul 11 2014]
Cycle challenge in memory of Henry [Published Fife Today - Jul 09 2014]
1 2 3
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
BSD Medical Hyperthermia Reports Initiation of ... [Published Business Wire Health News - Jul 15 2014]
SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that utilize heat therapy to treat cancer, today reported initiation of a Phase I/II study (HYPROSAR) using ...
The Texas Medical Board vs. Stanislaw Burzynski... [Published ScienceBlogs : Combined Feed - Jul 14 2014]
There’s a point I feel that I have have to make briefly as I begin this post. Basically, this might look familiar, but given that I was at TAM Wednesday through Sunday, I didn’t have time to produce two separate posts, and this is important enough ...
The Texas Medical Board vs. Stanislaw Burzynski... [Published Science-Based Medicine - Jul 14 2014]
As I begin this post, I’m no a miserably crowded, hot, stinky flight winging my way home from TAM . This puts me in the perfect mood to write about my bête noire to conquer all bêtes noires, namely Stanislaw Burzynski, the Polish expat doctor who ...
Nanobiotix revenues steady; investors focus on ... [Published Proactiveinvestors United Kingdom website - Jul 11 2014]
Nanobiotix (EPA:NANO), which is developing a significant advance on traditional radiotherapy, said revenues for the quarter were €48,596 – exactly the same as the comparable period last year. The majority of the income came in an upfront payment from ...
Orphan designation: Ombrabulin, for the: Treatm... [Published Orphan designations - Jun 19 2014]
1 2 3 4 5

Press Releases

sort by: Date | Relevance
NANOBIOTIX: sees Clinical Advance in Soft Tissu... [Published GlobeNewswire: Acquisitions News - Feb 10 2014]
TRACON Pharmaceuticals Initiates Phase 1b Study... [Published GlobeNewswire: Acquisitions News - Feb 03 2014]
Data Presented For ENMD-2076 In Preclinical Mod... [Published PR Newswire - Oct 21 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.